90083614

Information

  • Trademark
  • 90083614
  • Serial Number
    90083614
  • Filing Date
    July 30, 2020
    4 years ago
  • Transaction Date
    November 21, 2022
    2 years ago
  • Status Date
    November 21, 2022
    2 years ago
  • Published for Opposition Date
    February 23, 2021
    3 years ago
  • Location Date
    April 20, 2021
    3 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    BLACK, MILDRED ELIZABE
  • Attorney Docket Number
    140679526354
    Attorney Name
    Kristen S. Ruisi
    Law Office Assigned Location Code
    N30
  • Owners
Mark Drawing Code
2000
Case File Statements
  • GS0401: Custom manufacturing services in the nature of chemical processing and production of medicines and pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases
  • DM0000: The mark consists of a square design, within the square is a diamond within another stylized diamond.
  • GS0051: Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemico-pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; drugs in the nature of pharmaceutical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Injectable pharmaceuticals for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; crude drugs in the nature of pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Biochemical preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases
  • GS0351: Advertising services; personnel management consultancy; accounting services; business management assistance; sponsorship search; Retail or wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; marketing services; provision of an on-line marketplace for buyers and sellers of goods and services; systemization of information into computer databases
  • GS0441: Telemedicine services; health care; convalescent home services; beauty salon services; physical therapy services; gardening; veterinary services; health counseling; pharmacy advice, namely, pharmaceutical advice; rental of sanitary installations
  • GS0421: Research and development of new products for others; technological research in the field of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical research; conducting clinical trials for others for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological research; quality control for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; electronic data storage; material testing; cloud computing featuring software for use in database management, word processing, spreadsheet management, tracking; packaging design
Case File Event Statements
  • 11/21/2022 - 2 years ago
    34 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 11/21/2022 - 2 years ago
    33 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 4/7/2022 - 2 years ago
    32 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 4/5/2022 - 2 years ago
    31 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 4/5/2022 - 2 years ago
    30 - SOU EXTENSION 2 FILED Type: EXT2
  • 4/5/2022 - 2 years ago
    29 - TEAS EXTENSION RECEIVED Type: EEXT
  • 10/20/2021 - 3 years ago
    28 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/18/2021 - 3 years ago
    27 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 10/18/2021 - 3 years ago
    26 - SOU EXTENSION 1 FILED Type: EXT1
  • 10/18/2021 - 3 years ago
    25 - TEAS EXTENSION RECEIVED Type: EEXT
  • 4/20/2021 - 3 years ago
    24 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 2/23/2021 - 3 years ago
    23 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/23/2021 - 3 years ago
    22 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/3/2021 - 3 years ago
    21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/28/2021 - 3 years ago
    20 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 1/28/2021 - 3 years ago
    19 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 1/28/2021 - 3 years ago
    18 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 1/28/2021 - 3 years ago
    17 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 1/28/2021 - 3 years ago
    16 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 1/15/2021 - 3 years ago
    15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/15/2021 - 3 years ago
    14 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 1/15/2021 - 3 years ago
    13 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 1/15/2021 - 3 years ago
    12 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 1/15/2021 - 3 years ago
    11 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 1/6/2021 - 3 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/6/2021 - 3 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/6/2021 - 3 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/6/2020 - 4 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 11/6/2020 - 4 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 11/6/2020 - 4 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/5/2020 - 4 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/29/2020 - 4 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 8/28/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 8/3/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP